Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Breast Cancer Research : BCR|January 24, 2014
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2Carla De Giovanni, Giordano Nicoletti, Elena Quaglino, et al.
Translational Lung Cancer Research|December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLCFrancesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
Cancer Research|August 29, 2014
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumabLorenzo Castagnoli, Manuela Iezzi, Gaia C Ghedini, et al.
Scientific Reports|August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigationsPatrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.
Oncotarget|September 15, 2017
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic responseArianna Palladini, Giordano Nicoletti, Alessia Lamolinara, et al.
Oncoimmunology|February 6, 2018
Virus-like particle display of HER2 induces potent anti-cancer responsesArianna Palladini, Susan Thrane, Christoph M Janitzek, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Cancer & Metabolism|November 28, 2013
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cellsClaudia Calabrese, Luisa Iommarini, Ivana Kurelac, et al.
Pageof 8